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Improved identification of viable myocardium
using second harmonic imaging during
dobutamine stress echocardiography
F B Sozzi, D Poldermans, J J Bax, A Elhendy, E C Vourvouri, R Valkema, J De Sutter,
A F L Schinkel, A Borghetti, J R T C Roelandt
Abstract
Objective—To determine whether, compared with fundamental imaging, second harmonic
imaging can improve the accuracy of dobutamine stress echocardiography for identifying viable
myocardium, using nuclear imaging as a reference.
Patients—30 patients with chronic left ventricular dysfunction (mean (SD) age, 60 (8) years; 22
men).
Methods—Dobutamine stress echocardiography was carried out in all patients using both fun-
damental and second harmonic imaging. All patients underwent dual isotope simultaneous
acquisition single photon emission computed tomography (DISA-SPECT) with 99mtechnetium-
tetrofosmin/18F-fluorodeoxyglucose on a separate day. Myocardial viability was considered
present by dobutamine stress echocardiography when segments with severe dysfunction showed
a biphasic sustained improvement or an ischaemic response. Viability criteria on DISA-SPECT
were normal or mildly reduced perfusion and metabolism, or perfusion/metabolism mismatch.
Results—Using fundamental imaging, 330 segments showed severe dysfunction at baseline; 144
(44%) were considered viable. The agreement between dobutamine stress echocardiography by
fundamental imaging and DISA-SPECT was 78%, ê = 0.56. Using second harmonic imaging,
288 segments showed severe dysfunction; 138 (48%) were viable. The agreement between dob-
utamine stress echocardiography and DISA-SPECT was significantly better when second
harmonic imaging was used (89%, ê = 0.77, p = 0.001 v fundamental imaging).
Conclusions—Second harmonic imaging applied during dobutamine stress echocardiography
increases the agreement with DISA-SPECT for detecting myocardial viability.
(Heart 2001;86:672–678)
Keywords: dobutamine stress echocardiography; second harmonic imaging; 18F-fluorodeoxyglucose imaging;
myocardial viability
In patients with severe left ventricular dysfunc-
tion, myocardial revascularisation reduces
heart failure symptoms and improves long term
survival. There is a relation between the
amount of viable tissue and the expected ben-
efit of revascularisation.1 2 Various tests are
available and can broadly be divided into two
groups—nuclear testing and stress echocardio-
graphy. Single photon emission computed
tomography (SPECT) with either 201thallium
or 99mtechnetium labelled agents evaluates
myocardial perfusion, which is dependent on
cell membrane integrity and active cellular
uptake. Positron emission tomography evalu-
ates myocardial metabolism and allows the
detection of metabolic activity in the hypoper-
fused myocardium.3–6
Nuclear imaging techniques are more sensi-
tive than dobutamine stress echocardiography
for detecting viability.4 7 8 This is probably
because nuclear imaging techniques are based
on the detection of the integrity of the cell mem-
brane and of preserved perfusion and metabo-
lism (structural viability), whereas dobutamine
stress echocardiography relies on the assessment
of preserved contractile reserve (functional
viability).8 Dysfunctional myocardium that has
suVered more profound ultrastructural damage
will probably lose contractile reserve but can still
show intact cell membrane integrity and pre-
served perfusion and metabolism.9 10 Despite
this physiological explanation for the discrep-
ancy between the tests, technical limitations may
also be responsible for the discordance, owing to
the suboptimal segmental endocardial border
definition, present in at least 30% of patients
evaluated by echocardiography using funda-
mental imaging.11–15
Our aim in this study was to determine
whether second harmonic imaging can im-
prove the accuracy of dobutamine stress echo-
cardiography for identifying viable myocar-
dium compared with fundamental imaging,
using a dual isotope (99mtechnetium, tetrofos-
min and 18F-fluorodeoxyglucose) simultaneous
acquisition (DISA) method as a reference.16
Methods
PATIENTS
Thirty patients underwent both dobutamine
stress echocardiography and DISA-SPECT for
evaluation of myocardial viability. The tests
were performed in a random order within one
week. All patients underwent coronary angio-
graphy within three months of the two tests.
Patients were referred to our imaging labora-
tory for evaluation of myocardial viability and
were not selected on the basis of echocardio-
graphic or nuclear imaging quality. The
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characteristics of the patients are given in table
1. The local medical ethics committee ap-
proved the study protocol and all patients gave
informed consent to undergo the test.
DOBUTAMINE STRESS TEST
After baseline echocardiography, dobutamine
was infused at a starting dose of 5 µg/kg/min for
five minutes, followed by 10 µg/kg/min for five
minutes (low dose stage). The dobutamine
dose was increased by 10 µg/kg/min every three
minutes up to a maximum dose of 40 µg/kg/
min. Atropine (up to 2 mg) was given intrave-
nously at the end of the last stage if the target
heart rate was not achieved. End points of the
test were: achievement of target heart rate
(85% of the maximum heart rate predicted for
age); maximum dose of dobutamine and atro-
pine; extensive new wall motion abnormalities;
> 2 mV down sloping ST segment depression
measured 80 ms from the J point compared
with baseline; hypertension (blood pressure
> 240/120 mm Hg), a decrease in systolic
blood pressure of > 40 mm Hg compared with
rest, significant arrhythmias, or any intolerable
adverse eVect considered to be the result of
dobutamine or atropine. Metoprolol (1–5 mg)
was used intravenously to reverse the side
eVects of dobutamine.
ECHOCARDIOGRAPHIC IMAGING
Imaging was achieved with a Hewlett-Packard
Sonos 5500 ultrasonographic system (Hewlett-
Packard Inc, Andover, Massachusetts, USA).
We used a transducer operating at fundamental
frequencies of 1.8 or 2.1 MHz and collecting
second harmonic frequencies at 3.6 MHz or
4.2 MHz. Fundamental and second harmonic
images were obtained at rest, at low dose dob-
utamine infusion, and at peak dose dob-
utamine infusion. The images were continu-
ously recorded on videotape, and for both types
of imaging they were also digitised. Assessment
of the images was based both on the digitised
images displayed in a cineloop format and on a
review of the images recorded on the vide-
otape.
ECHOCARDIOGRAPHIC ANALYSIS
Two independent reviewers, blinded to the
DISA-SPECT and angiographic data, ran-
domly analysed fundamental imaging and sec-
ond harmonic imaging studies. In case of disa-
greement, a majority decision was achieved by
a third investigator. For segmental analysis of
left ventricular function, a 16 segment model
was used, as suggested by the American Society
of Echocardiography.17 Each segment was
scored for endocardial visualisation as follows:
0, not visualised; 1, poorly visualised; 2, well
visualised. Wall motion was scored at baseline,
at low dose dobutamine infusion, and at peak
stress. Each segment was scored using a five
point scale: 1, normal; 2, mild hypokinesis; 3,
severe hypokinesis; 4, akinesis; 5, dyskinesis.
Four diVerent patterns where defined in
segments with severe baseline dysfunction
(wall motion score > 2):
Biphasic response—Improvement of wall motion
during low dose (either at 5 or 10 µg/kg/min),
followed by worsening of wall motion during
high dose dobutamine.
Worsening—Deterioration of wall motion dur-
ing low or high dose dobutamine (ischaemic
response).
Sustained improvement—Continuous improve-
ment at low and high dose dobutamine
(without deterioration of wall motion).
No change—Absence of improvement or wors-
ening during the entire test.
Dysfunctional segments showing a biphasic,
sustained, or ischaemic response were classi-
fied as viable, whereas segments with un-
changed wall motion were considered non-
viable. Myocardial viability was considered
absent if akinetic segments became dyskinetic
during dobutamine stress echocardiography, as
shown previously.18
DISA-SPECT IMAGING
Patients received an intravenous dose of
600 MBq 99mtechnetium-tetrofosmin to evalu-
ate resting regional perfusion. To enhance car-
diac uptake of 18F-fluorodeoxyglucose, the
patients received an oral dose of 500 mg of
acipimox (Byk, Netherlands) orally, followed
by a carbohydrate enriched meal. Acipimox is a
potent nicotinic acid derivative that reduces
plasma levels of free fatty acids and stimulates
cardiac glucose (and 18F-fluorodeoxyglucose)
uptake. This meal stimulates endogenous insu-
lin release, thereby further promoting cardiac
glucose (and 18F-fluorodeoxyglucose) uptake.
18F-Fluorodeoxyglucose (185 MBq) was in-
jected 60 minutes after the meal. A 45 minute
period was allowed after the injection for myo-
cardial 18F-fluorodeoxyglucose uptake, fol-
lowed by the dual isotope simultaneous acqui-
sition SPECT. Data acquisition was performed
with a triple head gamma camera system
(Picker Prism 3000 XP, Cleveland, Ohio,
USA) equipped with 511 keV collimators. The
energies were centred on the 140 keV photon
peak of 99mtechnetium-tetrofosmin with a 15%
window and on the 511 keV photon peak of
18F-fluorodeoxyglucose with a 15% window.
Imaging was performed over 360° (120 sectors
of 3°) with a total imaging time of 32 minutes.
Table 1 Clinical and angiographic characteristics of the
study population
Characteristic (n=30) n (%)
Sex (male) 22 (73)
Age (years) 60 (8)*
Ejection fraction 37.7 (15.3)*
History of angina pectoris 26 (87)
Previous myocardial infarction 28 (93)
Anterior 15 (50)
Inferior 13 (43)
Hypertension 2 (7)
Hypercholesterolaemia 22 (73)
Diabetes mellitus 4 (13)
Smoking 10 (33)
â Blockers 20 (67)
Calcium channels blockers 9 (30)
Previous coronary artery bypass 10 (33)
Previous PTCA 7 (23)
Significant coronary artery disease 30 (100)
One vessel disease 13 (43)
Two vessel disease 10 (34)
Three vessel disease 7 (23)
*Mean (SD).
PTCA, percutaneous transluminal coronary angioplasty.
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Data were stored in a 64 × 64, 16 bit matrix.
The raw scintigraphic data were reconstructed
by filtered back projection using a Butterworth
filter (cut oV frequency at 0.17 cycle/pixel, of
order 3.5). No attenuation correction was
employed. Further reconstruction yielded
standard long and short axis projections
perpendicular to the heart axis. Reconstructed
slices were 6 mm in all projections.
DISA-SPECT ANALYSIS
The left ventricle was divided into 16 segments
(matching the echocardiographic segments).
Segmental activities were adjusted to peak myo-
cardial activity. Segments were divided into four
categories (assessed visually with the assistance
of normalised tracer activity): normal tracer
uptake (> 75% activity), mildly reduced tracer
uptake (50–75% activity), severely reduced
tracer uptake (< 50% activity), or absent tracer
uptake. The perfusion and 18F-fluorodeoxy-
glucose short axis slices were adjusted to peak
myocardial activity (100%).
The dysfunctional segments (identified at
resting echocardiography) were considered
viable if these showed normal perfusion and
normal 18F-fluorodeoxyglucose uptake (normal
activity), mildly reduced perfusion and mildly
reduced 18F-fluorodeoxyglucose uptake
(matched activity), or severely reduced/absent
perfusion with increased 18F-fluorodeoxy-
glucose uptake (mismatch).16 Segments with
reduced/absent perfusion and concomitant
severely reduced 18F-fluorodeoxyglucose up-
take were classified as non-viable.
CORONARY ANGIOGRAPHY
Coronary angiography was done within three
months of dobutamine stress echocardio-
graphy in all patients. Significant coronary
artery disease was defined as a diameter steno-
sis > 70% in one or more major epicardial
artery by quantitative analysis.19
The anterior, apical, septal, and anteroseptal
segments were assigned to the left anterior
descending coronary artery. The posterior and
lateral segments were assigned to the left
circumflex coronary artery. The inferior and
basal septal segments were assigned to the right
coronary artery. The apical lateral segment was
considered to be an overlap segment between
the left anterior descending and the left
circumflex coronary artery. The apical inferior
segment was considered to be an overlap
segment between the left anterior descending
and the right coronary artery. Overlap seg-
ments were assigned to the regions with
concomitant abnormality.20
STATISTICAL ANALYSIS
Continuous variables are expressed as mean
values (SD). Comparison of continuous vari-
ables was performed with the Student’s t test.
Comparison of proportions was performed
with the ÷2 test. Sensitivity and specificity were
presented with the corresponding 95% confi-
dence interval (CI). A probability value
p < 0.05 was considered significant.
The agreements between DISA-SPECT and
dobutamine stress echocardiography with fun-
damental imaging and second harmonic imag-
ing were defined as the percentage of concord-
ant diagnoses and were also assessed by
calculating the ê value: ê values between 0.75
and 1 were considered to show good agree-
ment, those between 0.40 and 0.75 to show
moderate agreement, and those between 0 and
0.40 to show poor agreement.
Results
No significant change in the patients’ symp-
toms or the clinical status occurred between
the nuclear and echocardiographic studies.
HAEMODYNAMIC DATA OF DOBUTAMINE STRESS
TEST
Dobutamine–atropine induced a significant
increase in heart rate (70 (15) beats/min at rest
to 131 (11) beats/min at peak stress,
p < 0.001), systolic blood pressure (125 (16) v
129 (24) mm Hg, p < 0.05) and rate–pressure
product (9432 (2870) to 16375 (6600),
p < 0.001). Test end points were target heart
rate in 27 patients (90%), maximum dose of
dobutamine and atropine in one patient (3%),
and angina in two patients (7%). No significant
arrhythmias or severe hypotension (decrease
systolic blood pressure > 40 mm Hg compared
with rest) occurred during the test.
DISA-SPECT
In the 30 patients, 480 segments were ana-
lysed. Normal perfusion and 18F-fluoro-
deoxyglucose uptake were observed in 222
segments (46%). Mildly reduced perfusion and
18F-fluorodeoxyglucose uptake were observed
in 80 segments (17%). A mismatch pattern was
found in 37 segments (8%). The remaining
141 segments (29%) had a matched reduction
in both perfusion and metabolism and were
classified as non-viable.
DOBUTAMINE STRESS ECHOCARDIOGRAPHY:
BASELINE CHARACTERISTICS
In all, 480 myocardial segments were analysed.
At baseline there was a higher prevalence of
segments with an invisible border (score = 0)
using fundamental imaging than using second
harmonic imaging (31 (12.7%) v 12 (10.2%),
p = 0.005). Analysis of wall motion score by
fundamental imaging at baseline showed 330
severely dysfunctional segments (73%), of
which 181 (55%) were akinetic/dyskinetic.
Analysis of wall motion score by second
harmonic imaging showed 288 dysfunctional
segments (61%; p < 0.001 v fundamental
imaging), of which 153 (53%) were akinetic/
dyskinetic (p = 0.02 v fundamental imaging).
The mean number (SD) of severely dysfunc-
tional segments per patient was 10.9 (3.5) with
fundamental imaging and 9.8 (3.2) with
second harmonic imaging.
Figure 1 represents the diVerent myocardial
patterns during dobutamine stress echocardio-
graphy with fundamental imaging and second
harmonic imaging in severe dysfunctional seg-
ments at baseline (wall motion score > 2).
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AGREEMENT BETWEEN DISA-SPECT AND
DOBUTAMINE STRESS ECHOCARDIOGRAPHY WITH
FUNDAMENTAL IMAGING AND SECOND HARMONIC
IMAGING
Fundamental imaging
With fundamental imaging, there were 330
segments with severe baseline dyssynergy. Of
these, 144 (44%) were considered viable by
both echocardiography and DISA-SPECT,
whereas 113 of the dysfunctional segments
(34%) were non-viable with both the tech-
niques. The agreement between dobutamine
stress echocardiography by fundamental imag-
ing and DISA-SPECT on the presence of
viability in severe dysfunctional segments was
78% (ê = 0.56), as shown in fig 2.
The agreement between fundamental imag-
ing and DISA-SPECT on the presence of
viability in akinetic/dyskinetic segments was
80% (ê = 0.59) (fig 3).
Second harmonic imaging
With second harmonic imaging, there were
288 segments with severe baseline dyssynergy.
Of these, 138 (48%) were viable with DISA-
SPECT, whereas 117 (41%) were non-viable
with both techniques. The agreement between
second harmonic imaging and DISA-SPECT
for the dysfunctional segments was 89%
(ê = 0.77) (p = 0.001 v fundamental imag-
ing).
The agreement between second harmonic
imaging and DISA-SPECT on the presence of
viability in akinetic/dyskinetic segments was
86% (ê = 0.72) (fig 3).
ACCURACY OF FUNDAMENTAL IMAGING AND
SECOND HARMONIC IMAGING FOR DETECTING
MYOCARDIAL VIABILITY
Using DISA-SPECT as the gold standard, we
determined the ability of dobutamine stress
echocardiography to detect viable tissue using
fundamental imaging and second harmonic
imaging. Dobutamine stress echocardiography
with fundamental imaging revealed signs of
viable tissue in 163 dysfunctional segments
(49%). This resulted in sensitivity for detecting
myocardial viability of 73% (144/198), with a
specificity of 86% (113/132) and an accuracy
of 78% (257/330).
When second harmonic imaging was used,
the number of viable segments was 151 (52%).
A significant improvement was obtained in
Figure 1 DiVerent myocardial patterns during
dobutamine stress echocardiography (DSE) by the use of
fundamental imaging (FI) and second harmonic imaging
(SHI).
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Figure 2 Agreement between DISA-SPECT and
dobutamine stress echocardiography (DSE), using
fundamental imaging (FI) and second harmonic imaging
(SHI), on the presence of myocardial viability in segments
with wall motion score > 2 (severe hypokinesis, akinesis, or
dyskinesis).
Dysfunctional segments: 288
Agreement DSE with FI v SPECT: 89%
k  = 0.77
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Figure 3 Agreement between DISA-SPECT and
dobutamine stress echocardiography (DSE), using
fundamental imaging (FI) and second harmonic imaging
(SHI), on the presence of myocardial viability in segments
with wall motion score > 3 (akinesis or dyskinesis).
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sensitivity (87% (138/158), p = 0.001 v funda-
mental imaging), and the accuracy was 88%
(255/288) (p = 0.001 v fundamental imaging),
whereas the specificity was similar at 90%
(117/130) (p = 0.4 v fundamental imaging)
(table 2).
Twelve segments were not visualised on
dobutamine stress echocardiography with sec-
ond harmonic imaging. Of these, eight were
non-viable on DISA-SPECT, two had normal
perfusion and normal metabolism, one had
mildly reduced perfusion and mildly reduced
metabolism, and one had absent perfusion and
increased metabolism.
In patients on â blocker treatment (20
patients), the agreement between dobutamine
stress echocardiography with fundamental im-
aging and DISA-SPECT was 77% (ê = 0.53).
The agreement between dobutamine stress
echocardiography with second harmonic imag-
ing and DISA-SPECT was 88% (ê = 0.77).
Myocardial segments were evaluated accord-
ing to the diVerent vascular territories. The
sensitivity for detecting myocardial viability in
the region of the left anterior descending, left
circumflex, and right coronary arteries is
shown in table 3. A significant improvement
occurred in the territory of the left anterior
descending coronary artery when second
harmonic imaging was used.
Myocardial viability was also assessed on an
individual patient basis. Patients were consid-
ered to have viable myocardium and to be can-
didates for revascularisation when four or more
dysfunctional segments showed viability by
dobutamine stress echocardiography.21 Ac-
cording to this approach, 24 patients were clas-
sified as having viable myocardium with both
fundamental imaging and second harmonic
imaging, five patients (17%) were classified as
having non-viable myocardium by fundamen-
tal imaging and viable myocardium by second
harmonic imaging, and one patient (3%) was
classified as having viable myocardium on fun-
damental imaging and non-viable myocardium
on second harmonic imaging.
Discussion
In this study we showed that the use of second
harmonic imaging during dobutamine stress
echocardiography improved the accuracy of
the detection of viable myocardium in patients
with severe left ventricular dysfunction com-
pared with fundamental imaging, DISA-
SPECT being used as a reference method.
Compared with fundamental imaging, the
agreement between dobutamine stress echo-
cardiography and DISA-SPECT on viability
assessment increased significantly from 78%
(ê = 0.56) to 89% (ê = 0.77) when second
harmonic imaging was used (p = 0.001).
Although the use of combined low/high dose
dobutamine echocardiography has improved
the accuracy of dobutamine stress echocardio-
graphy for detecting viability,21 22 there remains
some discordance between dobutamine echo-
cardiography and nuclear imaging.23–25
Previous studies have shown that 201thallium
classified a significantly higher percentage of
segments as viable compared with dobutamine
stress echocardiography.7 24 A similar discrep-
ancy was observed when 18F-fluorodeoxy-
glucose imaging with positron emission tom-
ography or SPECT was compared with
dobutamine stress echocardiography.3–5 Thus
the nuclear techniques appear to be more sen-
sitive for detecting viable myocardium, prob-
ably because the detection of myocardial
viability by these techniques requires a lesser
grade of cellular integrity than is needed to
elicit a contractile response during dob-
utamine echocardiography. From a patho-
physiological point of view, this discrepancy
can be explained by the fact that more severely
damaged myocardium (with less viable tissue
and more fibrosis) may still show perfusion
and glucose utilisation but has lost contractile
reserve.9
Technical factors may also contribute to the
discrepancy between dobutamine stress echo-
cardiography and nuclear imaging. Dob-
utamine stress echocardiography is influenced
by imaging quality to a greater extent than
nuclear techniques. A suboptimal acoustic
window may interfere with an accurate conclu-
sion regarding the presence or absence of
viable myocardium. In fact, a technically diY-
cult transthoracic visualisation reduces the
Table 2 Comparison of the accuracy between fundamental and second harmonic imaging during dobutamine stress echocardiography for the detection of
myocardial viability
Variable
Fundamental imaging
(n (%)) 95% CI
Second harmonic imaging
(n (%)) 95% CI p Value
Sensitivity for dysfunctional segments* 73% (144/198) 68 to 78 87% (138/158) 83 to 91 0.001
Specificity for dysfunctional segments* 86% (113/132) 82 to 89 90% (117/130) 86 to 94 0.40
Accuracy for dysfunctional segments* 78% (257/330) 73 to 82 89% (255/288) 85 to 92 0.001
Sensitivity for akinetic/dyskinetic segments** 75% (60/80) 68 to 82 90% (54/60) 85 to 95 0.06
Specificity for akinetic/dyskinetic segments** 84% (85/101) 78 to 90 84% (78/93) 78 to 90 0.90
Accuracy for akinetic/dyskinetic segments** 80% (145/181) 74 to 86 86% (132/153) 81 to 92 0.20
*Wall motion score > 2; **wall motion score > 3.
CI, confidence interval.
Table 3 Sensitivity and specificity of fundamental and second harmonic imaging and
agreement with nuclear studies in the three coronary territories
Regional arteries
Fundamental
imaging 95% CI
Second harmonic
imaging 95% CI p Value
LAD coronary artery
Agreement (ê value) 81% (0.56) 87% (0.69) 0.10
Sensitivity 84% (122/146) 79 to 89 93% (134/144) 90 to 97 0.02
Specificity 75% (47/63) 68 to 81 74% (49/66) 68 to 80 0.90
LCx coronary artery
Agreement (ê value) 87% (0.54) 91% (0.63) 0.40
Sensitivity 89% (114/128) 84 to 94 96% (121/126) 93 to 99 0.06
Specificity 73% (16/22) 65 to 80 63% (15/24) 55 to 70 0.70
Right coronary artery
Agreement (ê value) 80% (0.60) 88% (0.74) 0.10
Sensitivity 76% (53/70) 68 to 83 88% (64/73) 82 to 94 0.10
Specificity 86% (43/50) 80 to 92 87% (41/47) 81 to 93 0.90
LAD, left anterior descending; LCx, left circumflex.
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accuracy of the prediction of improvement in
left ventricular function after revascularisation.
In a recent study by Dalla Vecchia and
colleagues,26 18 patients with chronic coronary
artery disease referred for surgical revasculari-
sation were evaluated with dobutamine stress
echocardiography and dobutamine stress ra-
dionuclide ventriculography. The agreement
between these two techniques in predicting
improvement of function after revascularisa-
tion was suboptimal. This was mainly because
dobutamine stress echocardiography was less
sensitive, indicating underestimation of viable
tissue. However, when patients with optimal
visualisation of the endocardial border were
analysed separately, the sensitivity of dob-
utamine stress echocardiography increased sig-
nificantly. These results clearly show how the
lack of adequate endocardial border visualisa-
tion can lead to an underestimation of myocar-
dial viability.
The recent introduction of second harmonic
imaging has improved image quality by facili-
tating endocardial border detection. Previous
data have shown that second harmonic imaging
improves visualisation of endocardial borders
both at rest and during dobutamine stress
echocardiography.13 It has also been found that
second harmonic imaging is superior for
detection of coronary artery disease,27 but its
influence on viability assessment has not yet
been evaluated.
In this population of patients with ischaemic
left ventricular dysfunction, we evaluated myo-
cardial viability with a nuclear technique
(DISA-SPECT) and dobutamine stress echo-
cardiography, comparing both fundamental
imaging and second harmonic imaging. In dys-
functional segments, when using fundamental
imaging there was an evident discrepancy
between dobutamine stress echocardiography
and DISA-SPECT imaging (agreement 78%,
ê = 0.56). Second harmonic imaging increased
the agreement between the two methods
significantly (to 89%, ê = 0.77). The improve-
ment in sensitivity obtained with second
harmonic imaging in dysfunctional segments
mainly reflected a reduction in the number of
segments that were viable on SPECT and
non-viable on dobutamine stress echocardio-
graphy. This was particularly related to better
visualisation of the biphasic response (fig 1),
owing to better endocardial border visualisa-
tion.
The dobutamine stress echocardiography
studies were also analysed on an individual
patient basis. Using the four segment cut oV
level (allowing optimal identification of pa-
tients who will benefit from revascularisa-
tion),21 a diVerence between fundamental
imaging and second harmonic imaging was
obtained in six patients. Five of these were
classified as non-viable by fundamental imag-
ing but viable by second harmonic imaging.
Thus a substantial number of patients would
have been denied revascularisation based on
fundamental imaging.
Considering the three vascular territories, we
found a significant improvement in the sensi-
tivity in segments subtended by the left anterior
descending coronary artery (table 3). These
results are in line with previous work focusing
on the detection of coronary artery disease
using dobutamine stress echocardiography and
second harmonic imaging. In fact, the well
known phenomenon of endocardial “dropout”
is most often encountered in the lateral and
anterior walls (apical view).11–15
STUDY LIMITATIONS
This study used nuclear imaging as a reference
to define myocardial viability rather than
improvement in function. Thus the impact of
the use of second harmonic imaging on the
improvement of the ability of dobutamine
stress echocardiography for predicting func-
tional recovery after revascularisation needs
further evaluation.
The interval of three months between
dobutamine stress echocardiography and
angiography can be considered relatively long.
However, the clinical course of all these
patients was stable within this period.
CONCLUSIONS
Compared with fundamental imaging, second
harmonic imaging improves the agreement
between dobutamine stress echocardiography
and DISA-SPECT for detecting myocardial
viability in patients with ischaemic left ven-
tricular dysfunction.
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HLA-B27 positive juvenile arthritis with cardiac
involvement preceding sacroiliac joint changes
S J Lee,H Y Im,W C Schueller
While cardiovascular disease develops in up to 50% of
adult patients with ankylosing spondylitis, it is very
uncommon in its juvenile counterpart. Regarding the early
stage of the disease, before onset of sacroiliac joint changes,
only two cases with aortic incompetence have been
published while reports of mitral valve involvement are not
available. A 13 year old boy is described with an HLA-B27
positive asymmetric oligoarthritis and enthesitis, without
back pain or radiographic evidence of sacroiliitis. Echo-
cardiography showed an echogenic structure measuring
8 × 15 × 20 mm at the fibrous continuity between the aor-
tic and mitral valves extending through a false tendon into
an echogenic thickened posterior papillary muscle, causing
a grade II aortic and grade I/II mitral regurgitation. Short
term corticosteroid and long term non-steroidal anti-
inflammatory drug and disease modifying antirheumatic
drug treatments eYciently controlled the symptoms. The
cardiac findings remained unchanged during a follow up of
20 months. Careful cardiac evaluation appears to be man-
datory even in these young patients.
(Heart 2001;86:e19) www.heartjnl.com/cgi/content/full/
86/6/e19
Radiation induced valvulitis with late leaflet rupture
N M Katz, A W Hall,M D Cerqueira
Various cardiac sequelae of mediastinal irradiation have
been reported, from pericarditis to conduction defects.
Despite the potentially fatal nature of some of these abnor-
malities, many may present with few or no symptoms. In
this case report, the patient, who had received 4000 rads to
the mediastinum 24 years previously, presented with wors-
ening shortness of breath and two episodes of lightheaded-
ness. Subsequently, he was found to have aortic valve rup-
ture associated with fibrosis. A review of the literature
indicates that valve rupture is a novel consequence of
mediastinal radiation.
(Heart 2001;86:e20) www.heartjnl.com/cgi/content/full/
86/6/e20
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